Femasys Inc (FEMY)

Panoramica Notizia Cronologia dei prezzi Financials Perché FEMY Giù? Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Femasys Inc Stock (FEMY) Company Profile

Healthcare (1165)

770-500-3910

3950 JOHNS CREEK COURT, SUWANEE

Prossima data di guadagno

Ultimi documenti SEC

FEMY's Discussions on Twitter

Confronta FEMY con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FEMY Femasys Inc	1.285	28.17M	950.10K	-16.69M	-15.16M	-0.83
ISRG Intuitive Surgical Inc	501.14	177.83B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	225.24	66.11B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	92.36	45.54B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	220.94	32.66B	4.93B	1.25B	1.38B	8.47
BAX Baxter International Inc	33.62	17.19B	17.28B	108.00M	391.00M	0.20

Femasys Inc Borsa (FEMY) Ultime notizie

Femasys Inc Azioni (FEMY) Dati Finanziari

Femasys Inc (FEMY)

Femasys Inc Stock (FEMY) Company Profile

Confronta FEMY con altri titoli

Femasys Inc Borsa (FEMY) Ultime notizie

Femasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be Optimistic - Asianet Newsable

HC Wainwright Reaffirms “Buy” Rating for Femasys (NASDAQ:FEMY) - Defense World

Femasys Positioned for Growth with Innovative Products and Strategic Partnerships - TipRanks

H.C. Wainwright maintains Femasys stock Buy rating, $15 target - Investing.com India

H.C. Wainwright maintains Femasys stock Buy rating, $15 target By Investing.com - Investing.com Australia

Femasys earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada

Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Femasys reports FY24 EPS (85c), consensus (81c) - TipRanks

Femasys Inc. FY EPS USD -0.85 - Marketscreener.com

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update - GlobeNewswire

FEMASYS Earnings Preview: Recent $FEMY Insider Trading, Hedge Fund Activity, and More - Nasdaq

FY2026 Earnings Forecast for Femasys Issued By HC Wainwright - Defense World

HC Wainwright Boosts Femasys (NASDAQ:FEMY) Price Target to $15.00 - Defense World

H.C. Wainwright raises Femasys stock price target to $15 By Investing.com - Investing.com Australia

Femasys price target raised to $15 from $12 at H.C. Wainwright - Yahoo Finance

H.C. Wainwright raises Femasys stock price target to $15 - Investing.com

Femasys (FEMY) to Release Earnings on Thursday - Defense World

Femasys Gains Momentum with EU Approval and Strategic Partnerships, Boosting Buy Rating - TipRanks

Femasys Announces Partnership with CNY Fertility, National - GlobeNewswire

Femasys Secures Game-Changing Partnership: FemaSeed Now Available at 11 Leading Fertility Centers - StockTitan

Femasys’s Strategic Expansion and Promising Clinical Results Justify Buy Rating - TipRanks

Assessing Femasys: Insights From 4 Financial Analysts - Benzinga

Femasys Signs FemBloc Commercial Distribution Deals -March 18, 2025 at 09:58 am EDT - Marketscreener.com

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain - GlobeNewswire

Femasys Breaks Into European Market: First Global Deal for Revolutionary Birth Control Solution - StockTitan

HC Wainwright Reiterates “Buy” Rating for Femasys (NASDAQ:FEMY) - Defense World

H.C. Wainwright maintains Femasys stock Buy rating, $12 target By Investing.com - Investing.com South Africa

H.C. Wainwright maintains Femasys stock Buy rating, $12 target - Investing.com

Femasys gains CE mark for non-surgical birth control system By Investing.com - Investing.com Australia

Femasys Achieves CE Mark for FemBloc, Paving the Way for European Market Entry and Justifying Buy Rating - TipRanks

Femasys Receives CE Mark for FemBloc Non-Surgical Permanent Birth Control System - Femtech Insider

Femasys gains CE mark for non-surgical birth control system - Investing.com

Femasys Announces FemBloc Delivery System Approval in - GlobeNewswire

Revolutionary Breakthrough: Femasys Gets EU Approval for Non-Surgical Permanent Birth Control - StockTitan

Femasys announces FemBloc delivery system approval in Europe - TipRanks

Femasys Offers a Fresh Take on Women’s Reproductive Healthcare - MD+DI

Femasys gains UK approval for women's health products - MSN

Femasys’s FemBloc: A Promising Investment in Permanent Contraceptive Innovation - TipRanks

Femasys announces publication of ‘positive’ results from FemBloc trials - TipRanks

Femasys Announces Peer-Reviewed Publication of Positive - GlobeNewswire

Could This Non-Surgical Birth Control Method Replace Traditional Sterilization? Clinical Trials Say Yes - StockTitan

Femasys Inc Azioni (FEMY) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a FEMY